- Home
- OCUP vs SGRP Comparison
OCUP vs SGRP Comparison
Compare OCUP & SGRP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OCUP
- SGRP
- Stock Information
- Founded
- OCUP 2018
- SGRP 1967
- Country
- OCUP United States
- SGRP United States
- Employees
- OCUP N/A
- SGRP N/A
- Industry
- OCUP Biotechnology: Pharmaceutical Preparations
- SGRP Business Services
- Sector
- OCUP Health Care
- SGRP Consumer Discretionary
- Exchange
- OCUP Nasdaq
- SGRP Nasdaq
- Market Cap
- OCUP 53.1M
- SGRP 59.1M
- IPO Year
- OCUP N/A
- SGRP 1996
- Fundamental
- Price
- OCUP $1.32
- SGRP $2.48
- Analyst Decision
- OCUP Strong Buy
- SGRP
- Analyst Count
- OCUP 3
- SGRP 0
- Target Price
- OCUP $18.67
- SGRP N/A
- AVG Volume (30 Days)
- OCUP 86.6K
- SGRP 125.5K
- Earning Date
- OCUP 11-11-2024
- SGRP 11-12-2024
- Dividend Yield
- OCUP N/A
- SGRP N/A
- EPS Growth
- OCUP N/A
- SGRP N/A
- EPS
- OCUP N/A
- SGRP 0.52
- Revenue
- OCUP $16,449,000.00
- SGRP $258,415,000.00
- Revenue This Year
- OCUP N/A
- SGRP N/A
- Revenue Next Year
- OCUP $258.69
- SGRP N/A
- P/E Ratio
- OCUP N/A
- SGRP $4.80
- Revenue Growth
- OCUP N/A
- SGRP N/A
- 52 Week Low
- OCUP $1.15
- SGRP $0.70
- 52 Week High
- OCUP $3.53
- SGRP $3.12
- Technical
- Relative Strength Index (RSI)
- OCUP 48.70
- SGRP 72.05
- Support Level
- OCUP $1.25
- SGRP $1.42
- Resistance Level
- OCUP $1.35
- SGRP $2.43
- Average True Range (ATR)
- OCUP 0.08
- SGRP 0.02
- MACD
- OCUP 0.01
- SGRP -0.01
- Stochastic Oscillator
- OCUP 29.17
- SGRP 100.00
About OCUP Ocuphire Pharma Inc.
Ocuphire Pharma Inc is a clinical-stage ophthalmic biopharmaceutical company focused on developing and commercializing therapies for the treatment of refractive and retinal eye disorders. Ocuphire's pipeline includes two small molecular product candidates targeting the front and back of the eye indications. The Nyxol candidate is being developed for dim light or night vision disturbances, reversal of pharmacologically induced mydriasis, and presbyopia. The second product candidate, APX3330, is being developed for diabetic retinopathy and diabetic macular edema.
About SGRP SPAR Group Inc.
SPAR Group Inc is a supplier of merchandising and other marketing services. It also provides range of services to retailers, consumer goods manufacturers and distributors around the globe. The company divides its operations into three reportable regional segments: Americas, which is comprised of United States, Canada, Brazil and Mexico; Asia-Pacific (APAC), which is comprised of Japan, China, and India; and Europe, Middle East and Africa (EMEA), which is comprised of South Africa. It generates maximum revenue from Americas.